XML 52 R40.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue (Disaggregation of Revenue by Geographical Region) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jul. 01, 2022
Jun. 30, 2023
Jul. 01, 2022
Dec. 31, 2022
Disaggregation of Revenue [Line Items]          
Revenue $ 7,157 $ 7,751 $ 14,324 $ 15,439  
Recurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 5,338 5,892 10,724 11,790  
Nonrecurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 1,819 1,859 3,600 3,649  
North America          
Disaggregation of Revenue [Line Items]          
Revenue 2,927 3,382 5,949 6,736  
Western Europe          
Disaggregation of Revenue [Line Items]          
Revenue 1,708 1,691 3,416 3,519  
Other developed markets          
Disaggregation of Revenue [Line Items]          
Revenue 327 346 680 724  
High-growth markets          
Disaggregation of Revenue [Line Items]          
Revenue 2,195 2,332 4,279 4,460  
Environmental & Applied Solutions          
Disaggregation of Revenue [Line Items]          
Revenue         $ 4,800
Operating segments | Biotechnology          
Disaggregation of Revenue [Line Items]          
Revenue 1,885 2,266 3,749 4,482  
Operating segments | Biotechnology | Recurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 1,534 1,804 3,045 3,605  
Operating segments | Biotechnology | Nonrecurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 351 462 704 877  
Operating segments | Biotechnology | North America          
Disaggregation of Revenue [Line Items]          
Revenue 611 798 1,229 1,580  
Operating segments | Biotechnology | Western Europe          
Disaggregation of Revenue [Line Items]          
Revenue 684 632 1,331 1,339  
Operating segments | Biotechnology | Other developed markets          
Disaggregation of Revenue [Line Items]          
Revenue 72 88 151 173  
Operating segments | Biotechnology | High-growth markets          
Disaggregation of Revenue [Line Items]          
Revenue 518 748 1,038 1,390  
Operating segments | Life Sciences          
Disaggregation of Revenue [Line Items]          
Revenue 1,796 1,701 3,505 3,367  
Operating segments | Life Sciences | Recurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 1,104 1,068 2,143 2,105  
Operating segments | Life Sciences | Nonrecurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 692 633 1,362 1,262  
Operating segments | Life Sciences | North America          
Disaggregation of Revenue [Line Items]          
Revenue 757 778 1,465 1,516  
Operating segments | Life Sciences | Western Europe          
Disaggregation of Revenue [Line Items]          
Revenue 375 340 739 668  
Operating segments | Life Sciences | Other developed markets          
Disaggregation of Revenue [Line Items]          
Revenue 124 111 252 248  
Operating segments | Life Sciences | High-growth markets          
Disaggregation of Revenue [Line Items]          
Revenue 540 472 1,049 935  
Operating segments | Diagnostics          
Disaggregation of Revenue [Line Items]          
Revenue 2,231 2,561 4,607 5,205  
Operating segments | Diagnostics | Recurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 1,958 2,301 4,070 4,671  
Operating segments | Diagnostics | Nonrecurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 273 260 537 534  
Operating segments | Diagnostics | North America          
Disaggregation of Revenue [Line Items]          
Revenue 982 1,235 2,106 2,541  
Operating segments | Diagnostics | Western Europe          
Disaggregation of Revenue [Line Items]          
Revenue 365 453 785 977  
Operating segments | Diagnostics | Other developed markets          
Disaggregation of Revenue [Line Items]          
Revenue 100 115 217 239  
Operating segments | Diagnostics | High-growth markets          
Disaggregation of Revenue [Line Items]          
Revenue 784 758 1,499 1,448  
Operating segments | Environmental & Applied Solutions          
Disaggregation of Revenue [Line Items]          
Revenue 1,245 1,223 2,463 2,385  
Operating segments | Environmental & Applied Solutions | Recurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 742 719 1,466 1,409  
Operating segments | Environmental & Applied Solutions | Nonrecurring revenue          
Disaggregation of Revenue [Line Items]          
Revenue 503 504 997 976  
Operating segments | Environmental & Applied Solutions | North America          
Disaggregation of Revenue [Line Items]          
Revenue 577 571 1,149 1,099  
Operating segments | Environmental & Applied Solutions | Western Europe          
Disaggregation of Revenue [Line Items]          
Revenue 284 266 561 535  
Operating segments | Environmental & Applied Solutions | Other developed markets          
Disaggregation of Revenue [Line Items]          
Revenue 31 32 60 64  
Operating segments | Environmental & Applied Solutions | High-growth markets          
Disaggregation of Revenue [Line Items]          
Revenue $ 353 $ 354 $ 693 $ 687